What a decade of technology investment could mean for finding clients, preparing cases and defending a litigation portfolio.
Morgan & Morgan has committed at least $1 billion over ten years to technology and AI. If that investment reduces the cost of finding a client and preparing the evidence, cases that once cost too much to pursue could become economically viable.
That is the consequence defense leaders should examine: more legitimate cases may become worth bringing, even without an increase in underlying injuries.
On September 14, the firm unveiled MX2, its proprietary AI platform, with tools for case work inside Litify, document drafting and medical-record analysis. It described nearly $500 million of spending over the next five years. Source 1
Litify is the case-management system in this picture. MX2 is Morgan & Morgan's proprietary AI platform. The distinction matters: Bessemer acquired a majority stake in Litify in 2023. This announcement concerns the intelligence and work the firm is building around its operating system. Source 2
The useful way to read the investment is as two connected economic opportunities. One finds and retains clients. The other turns their evidence into cases that attorneys can advance. The strategic question is how each could improve the other.
There is already a disclosed result to examine. The MX2 website reports a 50% increase in selected output rates, including demands sent and discovery responses filed among active users. It does not provide the period, comparison cohort or quality-adjusted cost needed to translate that figure into firm-wide productivity. More demands is a measure of activity; it is not a measured increase in recoveries. Source 3
Even so, these are consequential activities. A chronology that reliably connects symptoms, treatment, prior injuries and disputed facts can shorten an attorney's preparation. A demand assembled from that record can be more complete on its first pass. Repeated across a large portfolio, reducing omissions and rework may matter as much as writing faster.
The tenfold possibility belongs here as a scenario. Suppose a repeatable task can be completed with one tenth the labor while preserving accuracy and attorney review. That does not make the entire practice ten times more productive. If half the work accelerates tenfold and half does not accelerate at all, overall labor capacity rises about 1.8 times. At an 80% automated share, the same calculation produces about 3.6 times capacity.
Those are illustrations, not estimates of MX2's performance. They expose where the larger gains would have to come from: changing the surrounding process, reducing handoffs and eliminating work that no longer needs to happen. Courts, clients, experts and records providers still operate on their own clocks.
Sentinel previously examined John Morgan's advertising ambitions. That earlier story is the context for this one: an organization that invests in acquiring clients now has another reason to connect intake with what happens after a client signs. Source 4
AI can make producing and testing advertising less expensive. But ten times as many ads is not ten times as many valuable clients. The demanding version of the acquisition thesis is ten times as many viable retained cases per advertising dollar, after accounting for quality and eventual case economics.
That requires more than creative volume. The system would need to improve which audiences it reaches, how quickly it responds, how accurately it qualifies an inquiry and whether the resulting case justifies the cost of acquiring and handling it. A campaign that produces cheap leads but expensive, unsuitable cases can worsen the business.
Advertising platforms already support bidding on differentiated conversion values and importing qualified-lead outcomes. That is infrastructure for a feedback loop; it is not evidence of Morgan & Morgan's configuration or results. The firm's announcement does not earmark its billion-dollar commitment for advertising or establish a tenfold acquisition gain. Source 5
A further possibility is that case outcomes make intake decisions better. Appropriate outcome signals could help distinguish a source of strong cases from a source of merely inexpensive inquiries. Sensitive medical and privileged records need not become advertising inputs for that economic lesson to matter.
Free weekly intelligence for executives responsible for litigation exposure: the named decision-makers, dollar exposure, operating consequence, and next development.
Consider the decision to accept a legitimate case. Expected fees must support the cost of finding the client, developing the evidence, doing the legal work and financing the time until resolution. If the handling cost falls, some cases that previously made little economic sense may become viable. That could expand access to representation and increase the number of claims a defense organization has to evaluate.
If acquisition also improves, the firm could direct more resources toward cases its process handles well. Better preparation could reduce avoidable delay; where actual resolution accelerates, capital could return sooner. Each mechanism reinforces the others only if the underlying evidence, quality and economics hold up.
This is why multiplying tenfold acquisition by tenfold productivity to predict one hundred times the lawsuits is the wrong calculation. Intake and case capacity constrain the same flow. Ten times more clients and capacity for ten times more cases can support ten times the throughput in a simplified system. They do not create one hundred times the throughput by multiplication.
The investment is still significant without that arithmetic. The competitive prize may be a lower cost of preparing a credible case and greater consistency across thousands of files. A large firm does not need every attorney to become its best attorney if it can reliably spread more of its best practices.
There is a second horizon. Morgan & Morgan says it intends to offer MX2 to other firms by invitation by the end of 2027, including corporate and transactional practices. That makes the development broader than a potential advantage for one plaintiff firm. It could become a platform business serving other parts of the legal market. Access, adoption and results remain to be seen. Source 1
The vulnerable interval is the time between a material development and an informed decision. A new medical record arrives. A demand changes. A deposition narrows the dispute. If the plaintiff team incorporates that development into its strategy while the defense's shared understanding waits for another report, the defense may lose time even when its lawyers are doing good work.
There is no reason to assume every AI improvement raises settlement values. Better evidence may expose weak claims or support fair earlier resolutions. Faster drafting may leave total case duration unchanged. A platform investment is not proof of courtroom superiority.
The executive response is nevertheless concrete: measure how quickly important facts become a current assessment and an owned action. Then measure what those actions accomplish. Ask whether outside counsel's work updates the shared record, whether comparable outcomes can be found, and whether settlement and defense choices are reviewed against the facts known at the time.
Morgan & Morgan has made a long commitment to improving how it operates. The defense's durable response is to make its own experience accumulate. Every resolved case contains information that the next case should not have to discover again.
Continue with the companion perspective: The Defense Must Make Every Case Improve the Next.
1. Morgan & Morgan. While Big Law Plans Morgan and Morgan Reveals It Has Been Quietly Building Proprietary In House AI. September 14, 2026. Company announcement; spending commitment and planned availability are forward-looking disclosures.
2. Goodwin. Bessemer Venture Partners Acquires Majority Stake in Litify. February 9, 2023. Transaction counsel announcement.
3. Morgan & Morgan. MX2. Retrieved September 14, 2026. Company-reported selected activity metrics; no disclosed controlled financial-outcome study.
4. Litigation Sentinel. 600 Million John Morgan Is Buying the Case. August 28, 2026. Prior editorial coverage, cited for continuity rather than independent verification of current advertising spend.
5. Google Ads Help. Working Together With AI to Provide It With the Highest Quality Inputs Possible. Retrieved September 14, 2026. Advertising-platform capability, not evidence of Morgan & Morgan's implementation.
The Executive Briefing has five questions about your reported litigation practices. Use the summary to choose an operating question to explore.
Take the Executive Briefing →Free weekly intelligence for executives responsible for litigation exposure: the named decision-makers, dollar exposure, operating consequence, and next development.